KDEV: Karolinska Development AB (publ) - Summary | Jitta

Karolinska Development AB (publ)

SWE:KDEV

Price
kr2.39
Loss Chance
54.3%
2.46JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (26)
Recent Business Performance (31)
Financial Strength (67)
Return to Shareholders (0)
Competitive Advantage (25)
Jitta Signs
Revenue and EarningEarning loss detected in 2021
Operating MarginDeclined
Recent Business PerformanceEarning decline 378.27% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
2.46
100.00%
COMPANY DESCRIPTION
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.